St. Jude medical CD3357-40Q UNIFY ASSURA ™ Cardiac Resynchronization Therapy (CRT) Defibrillator

(No reviews yet) Write a Review
SKU:
CD3357-40Q
MPN:
CD3357-40Q
Availability:
4-5 Business days
  • CD3357-40Q Bi-ventricular ICD Unify Assura Next Generation CRT-D 40 DF4 Connector
  • CD3357-40Q Bi-ventricular ICD Unify Assura Next Generation CRT-D 40 DF4 Connector
$79,395.00
Frequently bought together:

Description

 

CD3357-40Q Bi-ventricular ICD Unify Assura Next Generation CRT-D 40 DF4 Connector

 

UNIFY ASSURA 

CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

PRODUCT HIGHLIGHTS

  • TailoredTherapy features are designed to customize treatment to each patient's unique needs, including: SecureSense RV lead noise discrimination, ShockGuard® technology, SenseAbility® sensing algorithm and DeFT Response® technology
  • ShockGuard technology with DecisionTx® programming is designed to reduce inappropriate therapy and minimize the need for programming adjustments at implant
  • SecureSense RV lead noise discrimination detects sustained and short bursts of lead noise for the reduction of inappropriate shocks
  • Antitachycardia pacing (ATP) while charging and prior to charging in the VF zone further extends the programming options for terminating tachyarrhythmias without a high-voltage shock
  • The Low Frequency Attenuation filter is designed to enhance sensing performance and may reduce the possibility of oversensing T waves
  • Complete capture confirmation accounts for changing thresholds by automatically monitoring and controlling pacing amplitudes in all chambers of the heart
  • ACap® Confirm assesses capture threshold and adjusts pacing amplitudes in the atrium every eight or 24 hours
  • The SenseAbility sensing algorithm allows flexibility to fine-tune programming around T-wave oversensing without decreasing sensitivity
  • Streamlined DF4 connector simplifies implants and reduces pocket bulk
  • Highest amount of delivered energy (40 J) provides a greater safety margin
  • DeFT Response technology offers the most noninvasive options for managing high defibrillation thresholds (DFTs)
  • QHR®* battery chemistry provides greater capacity for enhanced longevity and improved charge time performance compared to previous SVO batteries
  • Unique vibratory notifier alerts patients to low battery, lead-related complications and more
  • Smallest footprint of any high-voltage device available and narrow shape allow smaller incision and pocket size
  • Triggered pacing with BiVCap® Confirm Trigger Mode helps maintain a high percentage of biventricular (BiV) pacing by triggering pacing in both the left and right ventricles in response to a sensed ventricular event
  • Negative AV hysteresis with search promotes ventricular pacing by automatically reducing the AV delay when intrinsic activity is present, thereby promoting a high degree of ventricular pacing
  • QuickOpt® Timing Cycle Optimization provides quick and effective AV and V-V timing optimization at the push of a button
Unify Assura<sup>™</sup>
 
 
View AllClose